317 related articles for article (PubMed ID: 28207623)
1. Feasibility of Percutaneous Posterolateral Spinal Fusion With Recombinant Bone Morphogenetic Protein-2 (rhBMP-2): A Comparison With Standard Methods Using an Animal Model Study.
Chan CY; Kwan MK; Saw LB; Paisal H
Clin Spine Surg; 2017 Mar; 30(2):E138-E147. PubMed ID: 28207623
[TBL] [Abstract][Full Text] [Related]
2. Is lumbar facet fusion biomechanically equivalent to lumbar posterolateral onlay fusion?
Toth JM; Foley KT; Wang M; Seim HB; Simon Turner A
J Neurosurg Spine; 2017 May; 26(5):586-593. PubMed ID: 28156207
[TBL] [Abstract][Full Text] [Related]
3. rhBMP-2 enhancement of posterolateral spinal fusion in a rabbit model in the presence of concurrently administered doxorubicin.
Singh K; Smucker JD; Ugbo JL; Tortolani PJ; Tsai L; Fei Q; Kuh S; Rumi M; Heller JG; Boden SD; Yoon ST
Spine J; 2007; 7(3):326-31. PubMed ID: 17482116
[TBL] [Abstract][Full Text] [Related]
4. rhBMP-6 stimulated osteoprogenitor cells enhance posterolateral spinal fusion in the New Zealand white rabbit.
Valdes M; Moore DC; Palumbo M; Lucas PR; Robertson A; Appel J; Ehrlich MG; Keeping HS
Spine J; 2007; 7(3):318-25. PubMed ID: 17482115
[TBL] [Abstract][Full Text] [Related]
5. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate.
Boden SD; Martin GJ; Morone MA; Ugbo JL; Moskovitz PA
Spine (Phila Pa 1976); 1999 Jun; 24(12):1179-85. PubMed ID: 10382242
[TBL] [Abstract][Full Text] [Related]
6. Initial fusion rates with recombinant human bone morphogenetic protein-2/compression resistant matrix and a hydroxyapatite and tricalcium phosphate/collagen carrier in posterolateral spinal fusion.
Glassman SD; Dimar JR; Carreon LY; Campbell MJ; Puno RM; Johnson JR
Spine (Phila Pa 1976); 2005 Aug; 30(15):1694-8. PubMed ID: 16094268
[TBL] [Abstract][Full Text] [Related]
7. Effect of recombinant human bone morphogenetic protein-2 in an experimental model of spinal fusion in a radiated area.
Ames CP; Smith JS; Preul MC; Crawford NR; Kim GE; Nottmeier E; Chamberlain R; Speiser B; Sonntag VK; Dickman CA
Spine (Phila Pa 1976); 2005 Dec; 30(23):2585-92. PubMed ID: 16319743
[TBL] [Abstract][Full Text] [Related]
8. RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of age.
Glassman SD; Carreon LY; Djurasovic M; Campbell MJ; Puno RM; Johnson JR; Dimar JR
Spine (Phila Pa 1976); 2008 Dec; 33(26):2843-9. PubMed ID: 19092613
[TBL] [Abstract][Full Text] [Related]
9. Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2.
Itoh H; Ebara S; Kamimura M; Tateiwa Y; Kinoshita T; Yuzawa Y; Takaoka K
Spine (Phila Pa 1976); 1999 Jul; 24(14):1402-5. PubMed ID: 10423783
[TBL] [Abstract][Full Text] [Related]
10. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion.
Akamaru T; Suh D; Boden SD; Kim HS; Minamide A; Louis-Ugbo J
Spine (Phila Pa 1976); 2003 Mar; 28(5):429-34. PubMed ID: 12616152
[TBL] [Abstract][Full Text] [Related]
11. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
Haid RW; Branch CL; Alexander JT; Burkus JK
Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
[TBL] [Abstract][Full Text] [Related]
12. Posterolateral lumbar spine fusion with INFUSE bone graft.
Glassman SD; Carreon L; Djurasovic M; Campbell MJ; Puno RM; Johnson JR; Dimar JR
Spine J; 2007; 7(1):44-9. PubMed ID: 17197332
[TBL] [Abstract][Full Text] [Related]
13. Use of recombinant human bone morphogenetic protein-2 as an adjunct in posterolateral lumbar spine fusion: a prospective CT-scan analysis at one and two years.
Singh K; Smucker JD; Gill S; Boden SD
J Spinal Disord Tech; 2006 Aug; 19(6):416-23. PubMed ID: 16891977
[TBL] [Abstract][Full Text] [Related]
14. Use of recombinant human bone morphogenetic protein-2 with local bone graft instead of iliac crest bone graft in posterolateral lumbar spine arthrodesis.
Park DK; Kim SS; Thakur N; Boden SD
Spine (Phila Pa 1976); 2013 May; 38(12):E738-47. PubMed ID: 23474598
[TBL] [Abstract][Full Text] [Related]
15. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
Khan TR; Pearce KR; McAnany SJ; Peters CM; Gupta MC; Zebala LP
Spine J; 2018 Mar; 18(3):439-446. PubMed ID: 28822825
[TBL] [Abstract][Full Text] [Related]
16. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model.
Namikawa T; Terai H; Suzuki E; Hoshino M; Toyoda H; Nakamura H; Miyamoto S; Takahashi N; Ninomiya T; Takaoka K
Spine (Phila Pa 1976); 2005 Aug; 30(15):1717-22. PubMed ID: 16094272
[TBL] [Abstract][Full Text] [Related]
17. RhBMP-2 is superior to iliac crest bone graft for long fusions to the sacrum in adult spinal deformity: 4- to 14-year follow-up.
Kim HJ; Buchowski JM; Zebala LP; Dickson DD; Koester L; Bridwell KH
Spine (Phila Pa 1976); 2013 Jun; 38(14):1209-15. PubMed ID: 23392417
[TBL] [Abstract][Full Text] [Related]
18. Quantitative study of parathyroid hormone (1-34) and bone morphogenetic protein-2 on spinal fusion outcomes in a rabbit model of lumbar dorsolateral intertransverse process arthrodesis.
Lina IA; Puvanesarajah V; Liauw JA; Lo SF; Santiago-Dieppa DR; Hwang L; Mao A; Bydon A; Wolinsky JP; Sciubba DM; Gokaslan Z; Holmes C; Witham TF
Spine (Phila Pa 1976); 2014 Mar; 39(5):347-55. PubMed ID: 24365898
[TBL] [Abstract][Full Text] [Related]
19. Graft resorption with the use of bone morphogenetic protein: lessons from anterior lumbar interbody fusion using femoral ring allografts and recombinant human bone morphogenetic protein-2.
Pradhan BB; Bae HW; Dawson EG; Patel VV; Delamarter RB
Spine (Phila Pa 1976); 2006 May; 31(10):E277-84. PubMed ID: 16648733
[TBL] [Abstract][Full Text] [Related]
20. Comparison of TLIF with rhBMP-2 versus no TLIF and higher posterolateral rhBMP-2 dose at L5-S1 for long fusions to the sacrum with sacropelvic fixation in patients with primary adult deformity.
Rahman RK; Buchowski JM; Stephens B; Dorward IG; Koester LA; Bridwell KH
Spine (Phila Pa 1976); 2013 Dec; 38(26):2264-71. PubMed ID: 24108280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]